Citation: Sj. Hadziyannis et D. Vassilopoulos, Immunopathogenesis of hepatitis B e antigen negative chronic hepatitis B infection, ANTIVIR RES, 52(2), 2001, pp. 91-98
Authors:
Panas, M
Kalfakis, N
Karadimas, C
Vassilopoulos, D
Citation: M. Panas et al., Episodes of generalized weakness in two sibs with the C164T mutation of the connexin 32 gene, NEUROLOGY, 57(10), 2001, pp. 1906-1908
Citation: Sj. Hadziyannis et D. Vassilopoulos, Complex management issues: management of HCV in the atypical patient, BEST PR RES, 14(2), 2000, pp. 277-291
Authors:
Petersen, MB
Karadima, G
Samaritaki, M
Avramopoulos, D
Vassilopoulos, D
Mikkelsen, M
Citation: Mb. Petersen et al., Association between presenilin-1 polymorphism and maternal meiosis II errors in Down syndrome, AM J MED G, 93(5), 2000, pp. 366-372
Citation: D. Vassilopoulos et al., Selected drug complications and treatment conflicts in the presence of coexistent diseases, RHEUM DIS C, 25(3), 1999, pp. 745
Authors:
Gyftodimou, J
Karadima, G
Pandelia, E
Vassilopoulos, D
Petersen, MB
Citation: J. Gyftodimou et al., Angelman syndrome with uniparental disomy due to paternal meiosis II nondisjunction, CLIN GENET, 55(6), 1999, pp. 483-486
Authors:
Panas, M
Karadimas, C
Avramopoulos, D
Vassilopoulos, D
Citation: M. Panas et al., Central nervous system involvement in four patients with Charcot-Marie-Tooth disease with connexin 32 extracellular mutations, J NE NE PSY, 65(6), 1998, pp. 947-948